Anzeige
Meldung des Tages: Goldchance mit Substanz: Warum dieses Projekt Investoren aufhorchen lässt

WuXi Biologics Aktie News

Aktie
WKN:  A2PQ3Q ISIN:  US98260N1081 US-Symbol:  WXXWY Branche:  Biotechnologie Land:  China
9,36 $
+0,01 $
+0,11%
7,9317 € 18:32:54 Uhr
Depot/Watchlist
Marktkapitalisierung *
14,59 Mrd. €
Streubesitz
100,00%
KGV
-
Faktor
0.5
Originalaktie
KYG970081173

WuXi Biologics News

16.05.25 - PR Newswire
WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-beta for Injection (Gaurunning) for Gaucher Disease by China NMPA
WuXi Biologics Congratulates Partner CANbridge Pharmaceuticals on the Approval of Innovative Velaglucerase-​beta for Injection (Gaurunning) for Gaucher Disease by China NMPA ...
13.05.25 - PR Newswire
WuXi Biologics Ireland: Delivering Measurable Sustainability Progress Through Purposeful Innovation
WuXi Biologics Ireland: Delivering Measurable Sustainability Progress Through Purposeful Innovation PR Newswire
29.04.25 - PR Newswire
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report
Driving Impact Through Responsibility: WuXi Biologics Releases 2024 Sustainability Report PR Newswire
22.04.25 - PR Newswire
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year
WuXi Biologics Recognized by CDP for Climate Change Leadership for Second Consecutive Year PR Newswire
18.04.25 - PR Newswire
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site PR Newswire
14.04.25 - PR Newswire
WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards
WuXi Biologics Wins Five Asia-​Pacific Biopharma Excellence Awards PR Newswire
25.03.25 - PR Newswire
WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025
WuXi Biologics Reports Solid 2024 Annual Results and Expects Accelerated Growth in 2025 PR Newswire
23.03.25 - PR Newswire
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year
WuXi Biologics Receives CDMO Leadership Awards for Eighth Consecutive Year PR Newswire
20.03.25 - PR Newswire
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year PR Newswire
10.03.25 - PR Newswire
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025
WuXi Biologics Included in S&P Global Sustainability Yearbook 2025 PR Newswire
03.03.25 - PR Newswire
WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production
WuXi Biologics Launches EffiX™ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production PR Newswire
26.02.25 - PR Newswire
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
WuXi Biologics Again Passed GMP Inspection by Japan PMDA PR Newswire
18.02.25 - PR Newswire
WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year
WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year PR Newswire
10.02.25 - PR Newswire
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +9,48%
Technical Trading: Pfund Short im Februar
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »